Nishant C. Saxena - 02 Jun 2026 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Reporting relationship: Chief Business Officer
Issuer ticker: CRBP
Reported as of: 02 Jun 2026
Net transaction value: +$101,218
SEC form: 4
Accepted by SEC: 03 Jun 2026, 17:36:50 UTC
Prior SEC filing: 22 May 2026
Source filing: View source filing
Reporting owner signature: /s/Meghan Houghton, Attorney-in-Fact for Nishant Saxena

Key filing fact

Nishant C. Saxena filed Form 4 for Corbus Pharmaceuticals Holdings, Inc. (CRBP) on 03 Jun 2026.

Key facts

This page summarizes Nishant C. Saxena's Form 4 filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2026, 17:36.

Change

Previous filing in this sequence was filed on 22 May 2026.
Current net transaction value: +$101,218.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002136365 Primary reporting owner

Saxena Nishant C

Relationship: Chief Business Officer
Address: C/O CORBUS PHARMACEUTICALS HOLDINGS, INC, 500 RIVER RIDGE DRIVE, NORWOOD
Signature: /s/Meghan Houghton, Attorney-in-Fact for Nishant Saxena
Signature date: 03 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRBP transaction

Common Stock, par value $0.0001 per share

Purchase

Transaction value: $32,998
Shares: +4,500
Change %: +7.3%
Price: $7.33
Shares after: 66,300
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F2

CRBP transaction

Common Stock, par value $0.0001 per share

Purchase

Transaction value: $68,220
Shares: +9,000
Change %: +14%
Price: $7.58
Shares after: 75,300
Date: 03 Jun 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.33 to $7.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule as previously reported.